ghk cu injection vs topical Copper Peptides: Do You Really Need to Inject Them? – Nubeean Noosa GHK-Cu Topical vs Injection |

Not for human or animal consumption, injection, diagnosis, treatment, or therapeutic application.

In fact, its unlikely to be well-absorbed enough to stand up to those claims

However, significant physiological differences between species must be considered when interpreting veterinary data for human clinical applications

Both remain in phase 3 clinical development programs [16]: Cagrilintide Status: Phase 3 trials ongoing for CagriSema (cagrilintide + semaglutide combination) Expected approval timeline: 2027-2028 for the combination product Monotherapy development pathway unclear Retatrutide Status: Phase 3 trials initiated in 2024-2025 Monotherapy development for obesity and metabolic dysfunction Expected approval timeline: 2028-2029 if trials succeed This regulatory status means any use of these compounds, whether individually or in cagrilintide dosage with retatrutide combinations, occurs in research contexts or through off-label prescribing once (if) individual approvals are obtained

Even if a site advertises third-party testing, theres no oversight or enforcement